For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Unicycive Therapeutics Inc (NASDAQ: UNCY) was $0.60 for the day, down -0.99% from the previous closing price of $0.61. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 0.66 million shares were traded. UNCY stock price reached its highest trading level at $0.62 during the session, while it also had its lowest trading level at $0.5852.
Ratios:
Our analysis of UNCY’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.64 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on April 21, 2025, initiated with a Buy rating and assigned the stock a target price of $6.
On April 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNCY now has a Market Capitalization of 72377400 and an Enterprise Value of 53156568.
Stock Price History:
The Beta on a monthly basis for UNCY is 1.99, which has changed by -0.4029851 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, UNCY has reached a high of $1.08, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 0.40%, while the 200-Day Moving Average is calculated to be 11.14%.
Shares Statistics:
UNCY traded an average of 894.08K shares per day over the past three months and 925510 shares per day over the past ten days. A total of 119.75M shares are outstanding, with a floating share count of 100.03M. Insiders hold about 17.08% of the company’s shares, while institutions hold 50.74% stake in the company. Shares short for UNCY as of 1745971200 were 793044 with a Short Ratio of 0.89, compared to 1743379200 on 1713889. Therefore, it implies a Short% of Shares Outstanding of 793044 and a Short% of Float of 0.69999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of Unicycive Therapeutics Inc (UNCY) is currently in progress, with 7.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.07, with high estimates of $0.04 and low estimates of -$0.11.
Analysts are recommending an EPS of between $0.08 and -$0.26 for the fiscal current year, implying an average EPS of -$0.1. EPS for the following year is $0.86, with 6.0 analysts recommending between $1.53 and $0.37.
Revenue Estimates
Based on 6 analysts’ estimates, the company’s revenue will be $330.79M in the next fiscal year. The high estimate is $599.94M and the low estimate is $174.39M.
